Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $29.33 USD
Change Today -0.11 / -0.37%
Volume 443.3K
CTLT On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 7:34 PM 06/30/15 All times are local (Market data is delayed by at least 15 minutes).

catalent inc (CTLT) Snapshot

Open
$29.74
Previous Close
$29.44
Day High
$29.74
Day Low
$29.17
52 Week High
05/29/15 - $32.11
52 Week Low
07/31/14 - $19.30
Market Cap
3.6B
Average Volume 10 Days
997.9K
EPS TTM
$1.08
Shares Outstanding
124.3M
EX-Date
--
P/E TM
27.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for CATALENT INC (CTLT)

catalent inc (CTLT) Related Businessweek News

No Related Businessweek News Found

catalent inc (CTLT) Details

Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. It operates through three segments: Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment provides advanced oral delivery technologies, including formulation, development, and manufacturing of oral dose forms for prescription and consumer health products. This segment’s oral dose forms include soft gel, modified release technologies, and immediate release solid oral products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development & Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also offers analytical chemical and cell-based testing and scientific services, stability testing, respiratory products formulation and manufacturing, regulatory consulting, and bioanalytical testing for biologic products. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.

8,300 Employees
Last Reported Date: 09/8/14
Founded in 2007

catalent inc (CTLT) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $850.0K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $625.0K
Senior Vice President of Global Operations
Total Annual Compensation: $493.1K
Senior Vice President of Global Marketing & S...
Total Annual Compensation: $411.6K
Compensation as of Fiscal Year 2014.

catalent inc (CTLT) Key Developments

Catalent, Inc. Presents at Jefferies 2015 Global Healthcare Conference, Jun-02-2015 02:00 PM

Catalent, Inc. Presents at Jefferies 2015 Global Healthcare Conference, Jun-02-2015 02:00 PM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: John R. Chiminski, Chief Executive Officer, President and Director, Matthew M. Walsh, Chief Financial Officer and Executive Vice President.

Catalent, Inc. Presents at William Blair’s 35th Annual Growth Stock Conference, Jun-09-2015 01:30 PM

Catalent, Inc. Presents at William Blair’s 35th Annual Growth Stock Conference, Jun-09-2015 01:30 PM. Venue: Four Seasons Hotel, Chicago, Illinois, United States. Speakers: Matthew M. Walsh, Chief Financial Officer and Executive Vice President.

Catalent, Inc. Presents at Goldman Sachs 36th Annual Global Healthcare Conference, Jun-11-2015 08:40 AM

Catalent, Inc. Presents at Goldman Sachs 36th Annual Global Healthcare Conference, Jun-11-2015 08:40 AM. Venue: Terranea Resort, Rancho Palos Verdes, California, United States. Speakers: Matthew M. Walsh, Chief Financial Officer and Executive Vice President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CTLT:US $29.33 USD -0.11

CTLT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hospira Inc $88.71 USD +0.02
STERIS Corp $64.44 USD -0.04
View Industry Companies
 

Industry Analysis

CTLT

Industry Average

Valuation CTLT Industry Range
Price/Earnings 37.7x
Price/Sales 2.0x
Price/Book 7.8x
Price/Cash Flow 42.7x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CATALENT INC, please visit www.catalent.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.